Accumulating studies have confirmed that IDH1 mutations are associated with the occurrence and development of glioma, and IDH1 mutations are more common in low grade glioma than in LGG (Miroshnikova et al., 2016). This evidence concerns the gene IDH1 and central nervous system cancer.